Lexeo Therapeutics (NASDAQ:LXEO) Price Target Cut to $20.00 by Analysts at Chardan Capital
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price target cut by Chardan Capital from $22.00 to $20.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other research analysts have also commented on LXEO. HC Wainwright reiterated a “buy” rating and set a […]
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price target cut by Chardan Capital from $22.00 to $20.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other research analysts have also commented on LXEO. HC Wainwright reiterated a “buy” rating and set a […]
